MENU
INDP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Indaptus Therapeutics (INDP) Ownership - Who owns Indaptus Therapeutics?

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

Profile

Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.61M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
59.51K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

INDP
Capitalization
6.61M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
59.5K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
2.8M
P/B Ratio
2.38
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
160K
Current Ratio
1.90
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
573K
Total Liabilities
2.61M
Total Volume MTD
N/A
Value
1
Gain YTD
-50.634
View a ticker or compare two or three
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com